Free Cash Flow Build Up
FibroGen Inc (FGEN)
$ 18.57
-0.24 (-1.28%)
Year A/P | 2013 Actual | 2014 Actual | 2015 Actual | 2016 Actual | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Projected | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected |
| Revenue | 102.17 | 137.60 | 180.83 | 179.58 | 125.67 | 212.96 | 256.58 | 176.32 | 200.01 | 226.88 | 257.36 | 291.93 | 331.16 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EBITDA | -2.87 | -45.63 | -71.95 | -47.61 | -116.51 | -80.13 | -67.86 | -169.83 | -88.85 | -100.78 | -114.32 | -129.68 | -147.11 |
| EBIT | -7.95 | -50.10 | -77.62 | -53.65 | -122.61 | -86.69 | -89.31 | -191.88 | -99.73 | -113.13 | -128.33 | -145.57 | -165.13 |
| Tax Rate | 0.00% | 0.00% | -0.28% | 0.11% | -0.26% | -0.35% | -0.43% | -0.19% | -0.17% | -0.17% | -0.17% | -0.17% | -0.17% |
| EBIAT | -7.95 | -50.10 | -77.84 | -53.59 | -122.92 | -87 | -89.70 | -192.25 | -99.90 | -113.33 | -128.55 | -145.82 | -165.41 |
| Depreciation | 5.08 | 4.47 | 5.68 | 6.04 | 6.10 | 6.56 | 21.45 | 22.05 | 10.88 | 12.34 | 14 | 15.88 | 18.02 |
| Accounts Receivable | - | 4.04 | -1.95 | 4.96 | 2 | -55.23 | 35.23 | -13.43 | 13.70 | -3.79 | -4.29 | -4.87 | -5.53 |
| Inventories | - | - | - | - | - | - | - | -9.64 | 4.47 | -1.62 | -1.84 | -2.08 | -2.36 |
| Accounts Payable | - | 3.49 | 1.97 | -0.30 | -0.71 | 3.63 | -3.05 | 18.70 | -15.66 | 1.23 | 1.39 | 1.58 | 1.79 |
| Capital Expenditure | -6.81 | -8.12 | -1.98 | -1.25 | -8.50 | -8.02 | -5.76 | -3.99 | -7.35 | -8.34 | -9.46 | -10.73 | -12.17 |
| UFCF | -9.67 | -46.22 | -74.12 | -44.15 | -124.04 | -140.06 | -41.83 | -178.56 | -93.85 | -113.50 | -128.74 | -146.04 | -165.66 |
| WACC | |||||||||||||
| PV UFCF | -70.21 | -73.43 | -72.04 | -70.68 | -69.35 | ||||||||
| SUM PV UFCF | -411.27 |